（This article only represents the author's own views.）
Hong Kong has been leading the world this year for investment returns on makers of novel drugs.
The HKEX Innovative Drug Index has soared 113% in 2025, far outpacing gains by the Nasdaq Biotechnology Index and the pharmaceutical stocks listed in mainland China.
您已閱讀7%（314字），剩余93%（4479字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。